Reversible complete atrioventricular block after percutaneous ASD device closure in a child <15 kg

Manoj Kumar Rohit1, Kriti Puri2, Ramalingam Vadivelu3

  • 1Additional Professor, Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India.

Indian Heart Journal
|June 30, 2014
PubMed

Insights

Transcatheter closure of atrial septal defects (ASD) in children under 15kg carries risks. Complete atrioventricular heart block (CHB) is a rare complication, but can resolve with steroid treatment.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Transcatheter device closure is a common treatment for atrial septal defects (ASDs).
  • Small children, particularly those weighing less than 15 kg, may face higher complication risks during ASD device closure.
  • Complete atrioventricular heart block (CHB) is a rare but serious complication associated with this procedure in pediatric patients.

Observation:

  • A case report details a 2-year-old girl weighing under 15 kg who underwent successful transcatheter closure of an ASD using an Amplatzer Septal Occluder.
  • Twelve hours post-procedure, the patient developed complete atrioventricular heart block (CHB).

Findings:

  • The CHB in this pediatric patient resolved completely by the fifth day following initiation of steroid treatment.
  • This case highlights that CHB can occur even with an adequate postero-inferior margin in small children undergoing ASD device closure.

Implications:

  • This case underscores the potential for rare complications like CHB in transcatheter ASD closure, even in technically suitable cases.
  • Early recognition and prompt steroid treatment may be effective in managing CHB post-ASD device closure in pediatric populations.
  • Further research into risk factors and management strategies for CHB in pediatric ASD device closure is warranted.